SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹63 Cr | ₹59 Cr | ₹54 Cr | ₹47 Cr | ₹33 Cr |
What is the latest Total Current Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹63 Cr |
| Mar2024 | ₹59 Cr |
| Mar2023 | ₹54 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹33 Cr |
How is Total Current Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹63 Cr | 6.99 | |
| Mar2024 | ₹59 Cr | 8.38 | |
| Mar2023 | ₹54 Cr | 16.50 | |
| Mar2022 | ₹47 Cr | 40.60 | |
| Mar2021 | ₹33 Cr | - | |
Compare Total Current Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,033.6 Cr | 7.8% | 9.7% | 161.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 7.8% |
9.7% |
161.4% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses